Cargando…
Interrogating the Genomic Landscape of Uterine Leiomyosarcoma: A Potential for Patient Benefit
SIMPLE SUMMARY: Uterine leiomyosarcoma is an aggressive and rare cancer that is difficult to treat. There are a number of mutations that are common to uterine leiomyosarcoma that are currently not routinely targeted therapeutically in this cancer type. In this review, we summarise the studies being...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946513/ https://www.ncbi.nlm.nih.gov/pubmed/35326717 http://dx.doi.org/10.3390/cancers14061561 |